With USD 25 million raised in Series B funding, Phable aims to create comprehensive healthcare ecosystem to help patients manage their condition more effectively
Phable, chronic disease management company has announced the appointment of Anuraag Dubey as Chief Product Officer (CPO) and Sagar Ramteke as Head of Corporate Development to strengthen company’s chronic care ecosystem and accelerate market expansion. With USD 25 million raised in Series B funding, Phable aims to create comprehensive healthcare ecosystem to help patients manage their condition more effectively.
Anuraag brings 23 years of experience to Phable. He has worked for companies such as Edureka and Practo prior to joining. He will play a crucial role in developing the company’s product and tech aligned with its mission to simplify chronic disease management via the Phable app.
Sagar is an accomplished business leader with more than two decades of experience in technology, business operations, strategic sourcing, sales, investments, and fundraising. He will report to Sumit Sinha, Phable’s co-founder and CEO, and will oversee the company’s M&A, fund raising, and strategic investments.
Talking about the two new appointments, Sumit Sinha & Mukesh Bansal, Founders of Phable in a joint statement said, “As we continue to grow towards our mission of helping Chronic Disease Patients to manage their ailment at lower costs and stay out of a hospital for as long as possible, Anuraag and Sagar’s extensive experience will be an immense asset to Phable. Our objective is to maximise our services full-scale to impact 1.6 billion lives, and by bringing industry veterans such as Sagar and Anuraag on board, we aim to expedite that process.”